Raymond James Adjusts Johnson & Johnson Price Target to $165 …

Jan 23, 2025 · Raymond James Adjusts Johnson & Johnson Price Target to $165 From $170, Maintains Outperform Rating January 23, 2025 at 08:20 am EST Share ... News Johnson …

CouponFollow Extension

$165
OFF

Raymond James Adjusts Johnson & Johnson Price Target To $165 …

3 weeks from now

Jan 23, 2025 · Raymond James Adjusts Johnson & Johnson Price Target to $165 From $170, Maintains Outperform Rating January 23, 2025 at 08:20 am EST Share ... News Johnson …

marketscreener.com

$165
OFF

Johnson & Johnson Price Target Lowered To $165 From $170 At …

3 weeks from now

Jan 23, 2025 · Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares. J&J’s Q4 results were solid, and its …

businessinsider.com

$165
OFF

Raymond James Adjusts Johnson & Johnson Price Target To $165 …

3 weeks from now

Jan 23, 2025 · -- Johnson & Johnson has an average rating of overweight and mean price target of $168.88, according to analysts polled by FactSet. ...

marketscreener.com

$165
OFF

Raymond James Maintains Outperform On Johnson & Johnson, …

3 weeks from now

Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $165. Benzinga·01/23/2025 14:04:28. Listen to the news. Raymond James analyst Jayson Bedford …

webull.com.sg

$170
OFF

Raymond James Maintains Outperform On Johnson & Johnson, …

3 weeks from now

Jan 23, 2025 · Raymond James analyst Jayson Bedford maintains Johnson Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $170 to $165.

sahmcapital.com

$175.00
OFF

What Analysts Are Saying About Johnson & Johnson Stock

3 weeks from now

Oct 10, 2024 · 17 analysts have expressed a variety of opinions on Johnson & Johnson ... Maintains: Outperform: $175.00: $175.00: Joshua Jennings: ... Raymond James: Maintains: …

nasdaq.com

$164
OFF

Raymond James Adjusts Price Target On Johnson & Johnson To …

3 weeks from now

-- Johnson & Johnson has an average rating of outperform and price targets ranging from $164 to $215, according to analysts polled by Capital IQ. Price: 171.2, Change: +1.01, Percent …

marketscreener.com

$165
OFF

Johnson & Johnson Named A 2025 Fortune World's Most Admired …

3 weeks from now

1 day ago · Raymond James Adjusts Johnson & Johnson Price Target to $165 From $170, Maintains Outperform Rating Jan. 23: MT Wells Fargo Cuts Johnson & Johnson Price Target …

marketscreener.com

$157
OFF

Raymond James Maintains Outperform On Johnson & Johnson

3 weeks from now

Raymond James maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $157 to $158. Benzinga · 07/17/2020 12:29 Raymond James maintains …

webull.com

$170.00
OFF

Raymond James Reiterates Outperform Rating On Johnson

3 weeks from now

Jan 22, 2025 · Raymond James analyst Jayson Bedford reiterated an Outperform rating and $170.00 price target on Johnson & Johnson (NYSE: JNJ)The analyst comments "Quick …

streetinsider.com

15%
OFF

How To Read Our Equity Research Reports - Raymond James

3 weeks from now

How to Read Our Equity Research Reports Raymond James & Associates (U.S.) definitions. Strong Buy (SB1) Expected to appreciate, produce a total return of at least 15%, and …

raymondjames.com

$53
OFF

HSF Inks $53 Million Construction Loan For 135-unit North Bergen …

3 weeks from now

Mar 8, 2023 · In a news release, the direct private lender said the first lien construction loan commitment will support the project at 8619 Bergenline Ave., known as The Braddock …

re-nj.com

FAQs about Raymond James Adjusts Johnson & Johnson Price Target to $165 … Coupon?

How do financial analysts perceive Johnson & Johnson?

The perception of Johnson & Johnson by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. ...

Does Johnson & Johnson have a good return on assets?

With an ROE of 6.62%, the company may need to address challenges in generating satisfactory returns for shareholders. Return on Assets (ROA): Johnson & Johnson's ROA excels beyond industry benchmarks, reaching 2.65%. This signifies efficient management of assets and strong financial health. ...

What happened to Johnson & Johnson?

Stay up to date on Johnson & Johnson analyst ratings. All You Need to Know About Johnson & Johnson Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. ...